PharmaSUG[removed]DS05 Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen Cui, Vertex Pharmaceuticals Incorporated Tathabbai Pakalapati, Cytel Inc.

First Page		Document Content
Date: 2013-05-05 15:43:25 Food and Drug Administration Respiratory therapy Technology SDTM FEV1/FVC ratio Pulmonary function testing Spirometry Clinical Data Interchange Standards Consortium Traceability Respiratory physiology Statistics Medicine		PharmaSUG[removed]DS05 Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen Cui, Vertex Pharmaceuticals Incorporated Tathabbai Pakalapati, Cytel Inc. Add to Reading List Source URL: www.pharmasug.org Download Document from Source Website File Size: 169,28 KB Share Document on Facebook

	Aquis Exchange Monthly Statistics Feb-2017 € 13,938,544,778 1,068,768,383 Value Traded DocID: 1xVY0 - View Document
	Aquis Exchange Monthly Statistics Feb-2016 € 5,995,146,,183,444 Nestle SA DocID: 1xVWK - View Document
	Aquis Exchange Monthly Statistics Feb-2018 € 17,012,038,916 1,321,056,240 Nestle SA DocID: 1xVRB - View Document
	Aquis Exchange Monthly Statistics May-2016 € 6,758,607,,245,455 Novartis AG DocID: 1xVO3 - View Document
	Aquis Exchange Monthly Statistics Month: Value traded (EUR): Volume (no. of shares): Jun-2017 DocID: 1xVNh - View Document